These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS? Azzam RS Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291 [TBL] [Abstract][Full Text] [Related]
5. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Hom C; Vaezi MF Drugs; 2013 Aug; 73(12):1281-95. PubMed ID: 23881666 [TBL] [Abstract][Full Text] [Related]
15. [Extraesophageal manifestations of gastroesophageal reflux disease]. Kim GH Korean J Gastroenterol; 2008 Aug; 52(2):69-79. PubMed ID: 19077497 [TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease and oral health: A narrative review. Mahajan R; Kulkarni R; Stoopler ET Spec Care Dentist; 2022 Nov; 42(6):555-564. PubMed ID: 35605234 [TBL] [Abstract][Full Text] [Related]
17. Respiratory manifestations of gastroesophageal reflux disease. Harding SM; Allen JE; Blumin JH; Warner EA; Pellegrini CA; Chan WW Ann N Y Acad Sci; 2013 Oct; 1300():43-52. PubMed ID: 24117633 [TBL] [Abstract][Full Text] [Related]
18. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Fouad YM; Katz PO; Hatlebakk JG; Castell DO Am J Gastroenterol; 1999 Jun; 94(6):1464-7. PubMed ID: 10364008 [TBL] [Abstract][Full Text] [Related]